Indacaterol/glycopyrronium versus tiotropium or glycopyrronium in long-acting bronchodilator-naïve COPD patients: A pooled analysis.

Shigeo MuroHajime Yoshisue Konstantinos KostikasPetter OlssonPritam GuptaJadwiga A Wedzicha

Published in: Respirology (Carlton, Vic.) (2019)

LABD-naïve patients treated with IND/GLY 110/50 μg q.d. achieved improvements in lung function, daily symptoms, dyspnoea, health-related quality of life and rescue medication use versus those who received single LAMA.

Keyphrases

lung function
chronic obstructive pulmonary disease
end stage renal disease
cystic fibrosis
air pollution
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
physical activity
patient reported outcomes